Anika Therapeutics, Inc. (ANIK) vs Treace Medical Concepts, Inc. (TMCI)

A side-by-side comparison of Anika Therapeutics, Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIK vs TMCI

growth of $100 · dividends reinvested · last 5y
ANIK -53.9% (-14.4%/yr)TMCI -82.5% (-29.4%/yr)ANIK compounded faster over this window
050100150Start $10020222023202420252026$46$18
ANIK TMCI

ANIK vs TMCI: by the numbers

  • •TMCI is the larger company ($259M vs $256M market cap).
  • •Both run net losses; ANIK's is the smaller (-3.14% vs -28.99% net margin).
  • •TMCI grew revenue faster over the past five years (21.44% vs -2.48% CAGR).

Metrics side by side

Valuation

MetricANIKTMCI
Forward P/E18.21N/A
P/S ratio2.121.26
P/B ratio1.863.83
EV / EBITDA473.06N/A
FCF yield0.22%N/A

Profitability

MetricANIKTMCI
Gross margin62.16%79.45%
Operating margin-4.24%-26.17%
Net margin-3.14%-28.99%
ROE-2.76%-87.86%
ROIC-3.17%-37.64%

Growth (annualized)

MetricANIKTMCI
Revenue CAGR (5Y)-2.48%21.44%
FCF CAGR (5Y)-39.38%N/A
Total return CAGR (5Y)-13.40%-29.41%

Frequently asked

Which has grown faster, ANIK or TMCI?
Over the past five years, TMCI grew revenue faster — ANIK at a -2.48% CAGR versus TMCI at 21.44%.
How have ANIK and TMCI total returns compared?
Over the past 5 years, ANIK delivered -13.40% and TMCI delivered -29.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.